Corcept Therapeutics Incorporated (NASDAQ:CORT) has received an average consensus rating of “Buy” from five brokerage firms currently covering the stock, according to Marketbeat Ratings. Analysts have...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received a consensus rating of “Buy” from the five brokerage firms currently covering its stock, according to a report by Marketbeat...
Research analysts at Mizuho have initiated coverage on shares of Primoris Services (NASDAQ: PRIM), assigning the construction company a “neutral” rating along with a price target...
Shares of Molson Coors Beverage Company (NYSE:TAP) have garnered a consensus recommendation of “Hold” from a network of sixteen research firms, according to data from MarketBeat...
